Review
Copyright ©2010 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Cardiol. Feb 26, 2010; 2(2): 34-42
Published online Feb 26, 2010. doi: 10.4330/wjc.v2.i2.34
Current advances in the understanding of coronary vasospasm
Ming-Jui Hung
Ming-Jui Hung, Cardiology Section, Department of Medicine, Chang Gung Memorial Hospital at Keelung, Chang Gung University College of Medicine, Keelung 20401, Taiwan, China
Author contributions: Hung MJ solely contributed to this paper.
Correspondence to: Ming-Jui Hung, MD, PhD, Cardiology Section, Department of Medicine, Chang Gung Memorial Hospital at Keelung, Chang Gung University College of Medicine, 222 Maijin Road, Keelung 20401, Taiwan, China. miran888@ms61.hinet.net
Telephone: +886-2-24313131-3168 Fax: +886-2-24335342
Received: January 21, 2010
Revised: February 10, 2010
Accepted: February 19, 2010
Published online: February 26, 2010
Abstract

Recent years have witnessed progress in our understanding of coronary vasospasm (CVS). It is evident that this is not only an East Asian but also a global disease associated with significant symptoms and possible lethal sequelae for afflicted individuals. A correct diagnosis depends on the understanding of pathogenesis and symptomatology of CVS. With the correct diagnosis, we can manage CVS patients effectively and promptly, providing optimal patient safety. Advances in our understanding of interactions between inflammation, endothelium, and smooth muscle cells have led to substantial progress in understanding the pathogenesis of symptoms in CVS and have provided some insights into the basic etiology of this disorder in some patient subpopulations. We look forward to a time when therapy will address pathophysiology and perhaps, even the primary etiology.

Keywords: Coronary vasospasm; Endothelial nitric oxide synthase; Inflammation; Nitric oxide; Rho-kinase